Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
-
Field
-
test them for RNA delivery and immunogenicity in vivo in preclinical models. We anticipate that nanoparticles will be a clinically translatable delivery system for RNA therapeutics. Candidate: We
-
conducting workshops, focus groups, and interviews, and developing and testing educational modules and an online learning portal. Additionally, the candidate will prepare presentations, manuscripts, and
-
transplantation into persons with type 1 diabetes. This will involve adding genes that will protect beta cells from stress, inflammation and adaptive immunity. These modified cells will first be tested by
-
tissues. The PDF will work with our interdisciplinary team to design and synthesize RNA constructs, then test them in vitro and in vivo for EV production, RNA delivery and targeting in preclinical models
-
tissues. The PDF will work with our interdisciplinary team to design and synthesize RNA constructs, then test them in vitro and in vivo for EV production, RNA delivery and targeting in preclinical models
-
secondary data collection including conducting interview (where appropriate); Partake in statistical testing such as mediator/moderator analyses of sample characteristics to identify sample criteria
-
health policy makers Zeina Waheed Doctor of Philosophy in Population and Public Health (PhD) Identification and evaluation of implementation strategies to advance the adoption of pharmacogenomic testing
-
partners. In these research projects we studied new diagnostic tests, therapies, service models, and technologies to optimize the physical and mental health of Canadian children born with brain-based